參展商名單

D&D Electronic Co. Ltd.

Researched Electrolyzed water from 1981, we are manufacturing Disinfectant Generator for Human Health. It has been installed more than 8,500 for Food Safety & Hygiene management without chemicals.

Tronex (HK) Ltd.

Founded in 1989, Tronex is a multiple-award-winning, leading global manufacturer and provider of superior-quality personal protective equipment (PPE) to the most selective foodservice, hospitality, hospitals, governments, and industrial markets, serving many of the Fortune 500 brands and distribution networks.

Gene Sincere Biotechnology Company Limited

Gene Sincere Biotechnology Company Limited (GS) is a biotechnology company engaged in the research & development, production, and commercialization of valuable products and expression systems. The unique features of the produced recombinant proteins are superbly pure, fully bioactive, authentic and effective for various applications.

Auiset Biotechnology Company Limited

Established in 2018, AUISET Biotechnology Co. Ltd. is a Hong Kong-based company specializing in “Aggregation-Induced Emission” (AIE) and In-Vitro Diagnostics (IVD) solutions. The discovery of the famous AIE phenomenon has brought new light to the healthcare world. AUISET is developing AIE-based health solutions focusing on women’s health, infectious diseases and etc.

DBS Bank (Hong Kong) Ltd.

DBS is a leading financial services group in Asia with a presence in 18 markets. Headquartered and listed in Singapore, DBS is in the three key Asian axes of growth: Greater China, Southeast Asia and South Asia. The bank’s “AA-” and “Aa1” credit ratings are among the highest in the world.
DBS provides a full range of services in consumer, private banking, SME and corporate banking. As a bank born and bred in Asia, DBS understands the intricacies of doing business in the region’s most dynamic markets. DBS is committed to building lasting relationships with customers, and positively impacting communities through supporting social enterprises, as it banks the Asian way.

科能三維技術(醫療)有限公司

KOLN 3D Technology (Medical) Ltd. is a pioneering metal 3D-printing medical supplier in Hong Kong, specializing in customized one-stop digital health solutions.
Bridging the expertise of doctors and bioengineers, KOLN 3D employs the latest AI and robotic technologies to produce patient-specific medical devices, including bone implants, surgical jigs, guides, and customized instruments, catering to each patient’s unique anatomy and surgeon’s specific needs.
We take initiative in revolutionizing the industry, setting up exemplar perimeters for quality control, and ensuring the safety, biocompatibility, and sustainability of our products as well as their manufacturing process.
KOLN 3D is a locally based company with global outreach, collaborating with academic and medical institutes across China, Asia, and Europe, exploring the possibilities of 3D printing, extending its clinical application beyond orthopedics, and continuously improving surgical outcomes.
We strive to restore and rejuvenate, for the benefit of the body, mind, and spirit.

GenScript Biotech (Singapore) PTE Ltd.

GenScript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody, and preclinical drug development service capabilities, we are internationally recognized as a leading biotech company specializing in fundamental life sciences research and early-phase drug discovery services. As of June 30, 2021, more than 64,700 peer-reviewed journal articles cited GenScript’s services and products, making GenScript the most frequently cited biotech company. Driven by the corporate mission of “making people and nature healthier through biotechnology”, GenScript strives to become the most trustworthy biotech company in the world.

The Pacific Life Assurance Co., Ltd.

The Pacific Life Assurance Co., Ltd. (‘Pacific Life’) was established in Hong Kong in 1960 and it is proud to be a local company growing together with Hong Kong.
Pacific Life has a very strong backup as a wholly-owned subsidiary of The Pacific Insurance Co., Ltd. which has long been an active and prudent player in the general insurance business with a good reputation in Hong Kong.
Pacific Life has fully committed to rendering quality life insurance services to the general public and has been focusing on providing a comprehensive range of life insurance products distributed through a strong network of insurance intermediaries to meet the diversified needs of the market.

李氏大藥廠控股有限公司

Lee’s Pharmaceutical (SEHK: 0950, www.leespharm.com) is an integrated research-driven and market-oriented biopharmaceutical company publicly listed in Hong Kong with over 25 years’ experience in the pharmaceutical industry in China. The Group focuses on several key disease areas such as cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology and obstetrics etc. Lee’s Pharmaceutical is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing based in Mainland China with global perspectives.

Lee’s Pharmaceutical (SEHK: 0950, www.leespharm.com) is an integrated research-driven and market-oriented biopharmaceutical company publicly listed in Hong Kong with over 25 years’ experience in the pharmaceutical industry in China.  The Group focuses on several key disease areas such as cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology and obstetrics etc.  Lee’s Pharmaceutical is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing based in Mainland China with global perspectives. 

Zhaoke Ophthalmology Limited

Zhaoke Ophthalmology (SEHK: 6622, www.zkoph.com) is a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet medical needs in the world. It has a comprehensive drug portfolio of innovative and generic treatments covering six major eye diseases across both the front and back of the eye. Many of the drugs are being produced in its state-of-the-art and fully functional development and manufacturing facility in Nansha, Guangzhou.

備註:

本網站內容可能包含參展商提供的產品、服務和宣傳資料。 BIOHK Ltd. 不對網站上發布的任何廣告材料負責。如果因廣告引起或與廣告有關的任何爭議,BIOHK Ltd. 保留在未經事先同意的情況下進行任何更改、刪除內容或終止協議的權利。